These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37548023)

  • 1. Tumor detection under cystoscopy with transformer-augmented deep learning algorithm.
    Jia X; Shkolyar E; Laurie MA; Eminaga O; Liao JC; Xing L
    Phys Med Biol; 2023 Aug; 68(16):. PubMed ID: 37548023
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmented Bladder Tumor Detection Using Deep Learning.
    Shkolyar E; Jia X; Chang TC; Trivedi D; Mach KE; Meng MQ; Xing L; Liao JC
    Eur Urol; 2019 Dec; 76(6):714-718. PubMed ID: 31537407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time Detection of Bladder Cancer Using Augmented Cystoscopy with Deep Learning: a Pilot Study.
    Chang TC; Shkolyar E; Del Giudice F; Eminaga O; Lee T; Laurie M; Seufert C; Jia X; Mach KE; Xing L; Liao JC
    J Endourol; 2023 Jul; ():. PubMed ID: 37432899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer.
    Mowatt G; Zhu S; Kilonzo M; Boachie C; Fraser C; Griffiths TR; N'Dow J; Nabi G; Cook J; Vale L
    Health Technol Assess; 2010 Jan; 14(4):1-331, iii-iv. PubMed ID: 20082749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.
    Witjes JA; Babjuk M; Gontero P; Jacqmin D; Karl A; Kruck S; Mariappan P; Palou Redorta J; Stenzl A; van Velthoven R; Zaak D
    Eur Urol; 2014 Nov; 66(5):863-71. PubMed ID: 25001887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry.
    Daneshmand S; Bazargani ST; Bivalacqua TJ; Holzbeierlein JM; Willard B; Taylor JM; Liao JC; Pohar K; Tierney J; Konety B;
    Urol Oncol; 2018 Aug; 36(8):361.e1-361.e6. PubMed ID: 29859728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III.
    Bach T; Bastian PJ; Blana A; Kaminsky A; Keller S; Knoll T; Lang C; Promnitz S; Ubrig B; Keller T; Qvick B; Burger M;
    World J Urol; 2017 May; 35(5):737-744. PubMed ID: 27578233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of blue-light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer.
    Lotan Y; Chaplin I; Ahmadi H; Meng X; Roberts S; Ladi-Seyedian S; Bagrodia A; Margulis V; Woldu S; Daneshmand S
    BJU Int; 2021 Jan; 127(1):108-113. PubMed ID: 32648957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of hexaminolevulinate (Hexvix(®)) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study.
    Lapini A; Minervini A; Masala A; Schips L; Pycha A; Cindolo L; Giannella R; Martini T; Vittori G; Zani D; Bellomo F; Cosciani Cunico S
    Surg Endosc; 2012 Dec; 26(12):3634-41. PubMed ID: 22729704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative predictive factors of carcinoma in situ in the normal-appearing mucosa in patients who underwent an initial transurethral resection for non-muscle-invasive bladder cancer under white light cystoscopy.
    Iinuma K; Yuhara K; Kotaka H; Ozawa K; Kato D; Takai M; Nakane K; Mizutani K; Tsuchiya T; Koie T
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1321. PubMed ID: 33174397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U-Net-Based Assistive Identification of Bladder Cancer: A Promising Approach for Improved Diagnosis.
    Guo Y; Li C; Zhang S; Zhu G; Sun L; Jin T; Wang Z; Li S; Zhou F
    Urol Int; 2024; 108(2):100-107. PubMed ID: 38081150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic impact of blue light cystoscopy in the management of NMIBC at US ambulatory surgical centers: what is the site-of-service disparity?
    Shore ND; Gavaghan MB
    Urol Oncol; 2023 Apr; 41(4):207.e9-207.e16. PubMed ID: 36564259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexvix blue light fluorescence cystoscopy--a promising approach in diagnosis of superficial bladder tumors.
    Geavlete B; Mulţescu R; Georgescu D; Geavlete P
    J Med Life; 2008; 1(3):355-62. PubMed ID: 20108513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic cystoscopy for bladder cancer diagnosis and for NMIBC follow-up: An overview of systematic reviews and meta-analyses.
    Soorojebally Y; Neuzillet Y; Lebret T; Allory Y; Descotes F; Ferlicot S; Kassab-Chahmi D; Lamy PJ; Oudard S; Rébillard X; Roy C; Roumiguié M; Rouprêt M; Audenet F
    Prog Urol; 2023 May; 33(6):307-318. PubMed ID: 37088584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and recurrence rate of transurethral resection of bladder tumors by narrow-band imaging: Prospective, randomized comparison with white light cystoscopy.
    Kim SB; Yoon SG; Tae J; Kim JY; Shim JS; Kang SG; Cheon J; Lee JG; Kim JJ; Kang SH
    Investig Clin Urol; 2018 Mar; 59(2):98-105. PubMed ID: 29520385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A deep learning network-assisted bladder tumour recognition under cystoscopy based on Caffe deep learning framework and EasyDL platform.
    Du Y; Yang R; Chen Z; Wang L; Weng X; Liu X
    Int J Med Robot; 2021 Feb; 17(1):1-8. PubMed ID: 32947648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a Spanish multicentre observational study.
    Palou J; Hernández C; Solsona E; Abascal R; Burgués JP; Rioja C; Cabrera JA; Gutiérrez C; Rodríguez O; Iborra I; Herranz F; Abascal JM; Conde G; Oliva J
    BJU Int; 2015 Jul; 116(1):37-43. PubMed ID: 25496450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder].
    Gakis G; Volkmer B; Qvick B; Marteau F; Stenzl A
    Urologe A; 2019 Jan; 58(1):34-40. PubMed ID: 29637215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
    Rink M; Babjuk M; Catto JW; Jichlinski P; Shariat SF; Stenzl A; Stepp H; Zaak D; Witjes JA
    Eur Urol; 2013 Oct; 64(4):624-38. PubMed ID: 23906669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blue light cystoscopy with hexylaminolevulinate: Our 7 years experience.
    Lacetera V; Cantoro U; Montesi L; Cantoro D; Cervelli B; Cicetti A; Gabrielloni G; Milella D; Montesi M; Morcellini R; Parri G; Recanatini E; Beatrici V
    Arch Ital Urol Androl; 2017 Mar; 89(1):39-41. PubMed ID: 28403596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.